Broad Market Momentum & Defensive Pivots: This Week’s Top ETF Flows

The ETF market saw a massive surge into core index heavyweights this past week, as investors poured billions into broad U.S. equities and mega-cap tech leadership. However, this aggressive accumulation was paired with deliberate defensive positioning in ultra-short Treasuries, spot gold, and healthcare sector exposure. This week’s inflows highlight a market leaning into U.S. equity momentum, while ensuring its safety nets remain firmly in place.Key Takeaways
Investors aggressively deployed capital across the U.S. equity market, pairing tech leadership in funds like the Invesco QQQ Trust Series I (QQQ) with massive inflows into core benchmarks like the Vanguard S&P 500 ETF (VOO).
Alongside equity momentum, investors funneled capital into defensive allocations such as short-duration Treasuries, spot gold, and healthcare equities.
Allocators looked beyond domestic borders for focused growth, deploying $757 million into the iShares MSCI South Korea ETF (EWY) to gain tactical exposure to global semiconductor leaders like Samsung and SK Hynix.
Top 10 InflowsMega-Cap Tech and Blue-Chip Momentum At the forefront of this week’s inflows were two distinct drivers of domestic market strength, mega-cap tech and large-cap blue-chips. The Invesco QQQ Trust Series I (QQQ B) led this week’s inflows gaining $7.85 billion in new assets as of August 6. Tracking the Nasdaq-100 Index, QQQ offers market-cap weighted exposure to the 100 largest non-financial companies listed on the Nasdaq. The strong inflows into QQQ underscores continued investor appetite for mega-cap tech exposure.
The State Street SPDR Dow Jones Industrial Average ETF Trust (DIA B) saw inflows of $1.90 billion over the course of the week, as earnings growth continued to broaden across U.S. markets. Tracking the Dow Jones Industrial Average Index, DIA provides concentrated exposure to 30 U.S. large-cap blue-chip stocks chosen by representatives from S&P Dow Jones Indices and The Wall Street Journal.Investing in the Broad U.S. MarketCapital continued to pour into broad-market index funds this week, as investors looked to capture broader U.S. market growth. Leading this charge were S&P 500 heavyweights, with the Vanguard S&P 500 ETF (VOO A) gathering $7.34 billion and the iShares Core S&P 500 ETF (IVV A) pulling in $4.34 billion this week. Further expanding this core equity accumulation, the State Street SPDR Portfolio S&P 500 ETF (SPYM) added $1.18 billion in new assets.
Covering the entire investable U.S. market, the Vanguard Morningstar Total Stock Market ETF (VTI A) received $1.80 billion in inflows this week. Tracking the CRSP US Total Market Index, VTI offers market-cap weighted exposure to roughly 3,500 holdings across various sectors and market capitalizations. By providing exposure to mid- and small-cap companies, VTI allows investors to capture broader U.S. market growth beyond traditional mega-cap tech.Prioritizing Safety and StabilityAlongside allocations to large-cap equities was a distinct turn toward defensive positioning. The iShares 0-3 Month Treasury Bond ETF (SGOV A+) saw $1.23 billion in new assets this week. SGOV attracted strong inflows as investors prioritized capital preservation and looked to manage ongoing macroeconomic uncertainties.
The SPDR Gold Shares (GLD B) gained $1.01 billion in new assets over the course of the week. This was driven by geopolitical developments, a sliding dollar, and easing Federal Reserve interest rate hike expectations. Spot gold is trading above $4,400 an ounce as of early afternoon trading on August 7, as cooling inflation pressures lower the opportunity cost of holding non-yielding assets.
Rounding out the week’s defensive allocations was a rotation into healthcare equities. The State Street Health Care Select Sector SPDR ETF (XLV A) captured $748 million in new assets this week. These gains were driven in part by strong second-quarter earnings from major healthcare providers such as Eli Lilly (LLY) and CVS Health (CVS). At the same time, investors sought equity exposure while leaning on the steady dividends and inelastic demand typical of the healthcare industry.Betting on South Korean SemiconductorsStepping outside U.S. markets, investors also looked overseas for targeted, international growth opportunities. The iShares MSCI South Korea ETF (EWY B) tracking the MSCI Korea 25-50 Index captured $757 million in fresh inflows. Investors used the single-country fund as a tactical play to gain exposure to global technology and semiconductor demand. Major South Korean semiconductor producers such as Samsung Electronics (005930) and SK Hynix (SKHY) collectively account for approximately 43% of EWY’s total assets.
For more news, information, and analysis, visit the Equity ETF Content Hub.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.